Medical tourism is the practice of traveling abroad to obtain medical treatment. In the past, this usually referred to those who traveled from less-developed countries to major medical centers in highly developed countries for treatment unavailable at home. However, in recent years it may equally refer to those from developed countries who travel to developing countries for lower-priced medical treatments. With differences between the medical agencies, such as the Food and Drug Administration (FDA) or the European Medicines Agency (EMA), etc., which decide whether a drug is approved in their country or region, or not, the motivation may be also for medical services unavailable or non-licensed in the home country.
The University of Texas MD Anderson Cancer Center is a comprehensive cancer center in Houston, Texas. It is the largest cancer center in the world and one of the original three NCI-designated comprehensive cancer centers in the country. It is both a degree-granting academic institution and a cancer treatment and research center located within Texas Medical Center (TMC), Houston, the largest medical center and life sciences destination in the world. MD Anderson Cancer Center has consistently ranked #1 among the best hospitals for cancer care and research in the U.S. and worldwide, and it has held the #1 position 20 times in the last 23 years in U.S. News & World Report's Best Hospitals rankings for cancer care. As of 2023, MD Anderson Cancer Center is home to the highest number of cancer clinical trials in the world and has received more NCI-funded projects than any other U.S. institute. In 2024, Newsweek placed MD Anderson at #1 in their annual list of the World's Best Specialized Hospitals in oncology.
Alopecia universalis(AU), also known as alopecia areata universalis, is a medical condition involving the loss of all body hair, including eyebrows, eyelashes, chest hair, armpit hair, and pubic hair. It is the most severe form of alopecia areata (AA). People with the condition are usually healthy and have no other symptoms and a normal life expectancy.
Roswell Park Comprehensive Cancer Center is a cancer research and treatment center located in Buffalo, New York. Founded by surgeon Roswell Park in 1898, the center was the first in the United States to specifically focus on cancer research. The center is usually called Roswell Park in short. The center, which conducts clinical research on cancer as well as the development new drugs, provides advanced treatment for all forms of adult and pediatric cancer, and serves as a member of the National Comprehensive Cancer Network. Roswell Park Comprehensive Cancer Center is as of 2019, the only upstate New York facility to hold the National Cancer Institute designation of "comprehensive cancer center".
Moffitt Cancer Center & Research Institute is a nonprofit cancer treatment and research center located in Tampa, Florida. Established in 1981 by the Florida Legislature, the hospital opened in October 1986 on the University of South Florida's campus. Moffitt is one of two National Cancer Institute-designated Comprehensive Cancer Centers based in Florida. In 2021, U.S. News & World Report ranked Moffitt Cancer Center as a top 30 cancer hospital in the United States.
Cryoablation is a process that uses extreme cold to destroy tissue. Cryoablation is performed using hollow needles (cryoprobes) through which cooled, thermally conductive fluids are circulated. Cryoprobes are positioned adjacent to the target in such a way that the freezing process will destroy the diseased tissue. Once the probes are in place, the attached cryogenic freezing unit removes heat from ("cools") the tip of the probe and by extension from the surrounding tissues.
Steven A. Rosenberg is an American cancer researcher and surgeon, chief of Surgery at the National Cancer Institute in Bethesda, Maryland and a Professor of Surgery at the Uniformed Services University of Health Sciences and the George Washington University School of Medicine and Health Sciences. He pioneered the development of immunotherapy that has resulted in the first effective immunotherapies and the development of gene therapy. He is the first researcher to successfully insert foreign genes into humans.
Tianhe District is one of the eleven districts of Guangzhou, the capital of Guangdong province. In Chinese, the name Tianhe literally means "a river in the sky/heavens", which is also a Chinese name for the Milky Way. It is bordered by Yuexiu District on the west, Baiyun District on the north and Huangpu District on the east. Haizhu District is on its south, though they are separated by the Pearl River.
Yuexiu District is one of 11 urban districts of the prefecture-level city of Guangzhou, the capital of Guangdong Province, China, located west of the Tianhe District and east of the Liwan District. It is the commercial, political and cultural centre of Guangdong and noted for its high-quality education. The Guangdong provincial government and the Guangzhou city government are both located in the Yuexiu District. Established in 1960, the district absorbed the former Dongshan District in May 2005 along with several former subdistricts of the Baiyun and Tianhe district. Yuexiu District has 18 streets under its jurisdiction. The total area is 33.8 square kilometers. According to the seventh census data, as of 0:00 on 1 November 2020, the resident population of Yuexiu District was 1,038,643.
Tiyu Xilu Station is an interchange station on Line 1 and Line 3 of the Guangzhou Metro. It started operations on 28 June 1999 and 26 December 2005. It is situated under Tiyu Road West (体育西路) and Tianhe 1st South Road (天河南一路) in the Tianhe District of Guangzhou. It is near Teemall (天河城广场) and Guangzhou Books Center (广州购书中心), which makes it one of the busiest metro stations in Guangzhou.
Oncology is a branch of medicine that deals with the study, treatment, diagnosis, and prevention of cancer. A medical professional who practices oncology is an oncologist. The name's etymological origin is the Greek word ὄγκος (ónkos), meaning "tumor", "volume" or "mass". Oncology is concerned with:
Line 6 of the Guangzhou Metro runs from Liwan District to Huangpu District. It starts at Xunfenggang and ends at Xiangxue, interchanging with Line 5 at Tanwei and Ouzhuang; Line 1 at Huangsha and Dongshankou; Line 8 at Cultural Park; Line 2 at Haizhu Square; Line 21 at Suyuan; Line 3 at Yantang and Tianhe Coach Terminal. The total length is 41.9 km (26.04 mi) with 32 stations. Line 6 serves densely populated areas including residential communities in Jinshazhou, the pedestrian street in Beijing Lu and wholesale markets in Shahe. Nevertheless, Line 6, which runs four-car trains, has long had a questionable train capacity. The phase one section between Xunfenggang and Changban began to provide service from 28 December 2013 with the exception of Yide Lu and Shahe stations. Yide Lu opened over a year later on 28 January 2015. The second phase of Line 6 from Changban to Xiangxue has been in operation since 28 December 2016. Like Lines 4 and 5, Line 6 is equipped with linear induction motor technology. Line 6's color is maroon.
Seattle Cancer Care Alliance (SCCA) is a cancer treatment and research center in Seattle, Washington. Established in 1998, this nonprofit provides clinical oncology care for patients treated at its three partner organizations: Fred Hutchinson Cancer Research Center, Seattle Children's and UW Medicine. Together, these four institutions form the Fred Hutch/University of Washington Cancer Consortium.
Niu Lizhi is a Chinese surgeon who specializes in minimally invasive cryosurgery for cancers. In 1996, he graduated from the Fourth Military Medical University with a doctoral degree in Thoracic & Cardiac Surgery.
Xu Kecheng is a Chinese specialist in gastroenterology, hepatology and cancer treatment and president of Guangzhou Fuda Cancer Hospital. Born in Nantong, Jiangsu Province, Xu Kecheng graduated from Nantong Medical College. He is honorary Chairman of the International Society of Cryosurgery (ISC). He was awarded the "Bethune Medal" in 2012 for his contributions to China's national healthcare system. In 2014, he was awarded the title of "the Role Model of the Times" by the Propaganda Department of the Central Committee of the CPC.
Akseli Hemminki July 27, 1973 (Helsinki) is a Finnish specialist in Oncology and Radiotherapy, Professor of Oncology and founder of two biotechnology companies.
Cryoimmunotherapy, also referred to as cryoimmunology, is an oncological treatment for various cancers that combines cryoablation of tumor with immunotherapy treatment. In-vivo cryoablation of a tumor, alone, can induce an immunostimulatory, systemic anti-tumor response, resulting in a cancer vaccine—the abscopal effect. Thus, cryoablation of tumors is a way of achieving autologous, in-vivo tumor lysate vaccine and treat metastatic disease. However, cryoablation alone may produce an insufficient immune response, depending on various factors, such as high freeze rate. Combining cryotherapy with immunotherapy enhances the immunostimulating response and has synergistic effects for cancer treatment.
This is a historical timeline of the development and progress of cancer treatments, which includes time of discovery, progress, and approval of the treatments.
Elizabeth M. Jaffee is an American oncologist specializing in pancreatic cancer and immunotherapy.
Combinatorial ablation and immunotherapy is an oncological treatment that combines various tumor-ablation techniques with immunotherapy treatment. Combining ablation therapy of tumors with immunotherapy enhances the immunostimulating response and has synergistic effects for curative metastatic cancer treatment. Various ablative techniques are utilized including cryoablation, radiofrequency ablation, laser ablation, photodynamic ablation, stereotactic radiation therapy, alpha-emitting radiation therapy, hyperthermia therapy, HIFU. Thus, combinatorial ablation of tumors and immunotherapy is a way of achieving an autologous, in-vivo tumor lysate vaccine and treating metastatic disease.
